Antithrombin III deficiency: Difference between revisions
No edit summary |
No edit summary |
||
(6 intermediate revisions by 4 users not shown) | |||
Line 14: | Line 14: | ||
'''For patient information click [[Antithrombin III deficiency (patient information)|here]]''' | '''For patient information click [[Antithrombin III deficiency (patient information)|here]]''' | ||
{{Antithrombin III deficiency}} | {{Antithrombin III deficiency}} | ||
{{CMG}} | {{CMG}}; {{AE}}{{MKA}}, {{S.G.}} | ||
== | {{SK}} Antithrombin 3 deficiency, Congenital AT-III Deficiancy, | ||
==[[Antithrombin III deficiency overview|Overview]]== | |||
==[[Antithrombin III deficiency historical perspective|Historical Perspective]]== | |||
==[[Antithrombin III deficiency pathophysiology|Pathophysiology]]== | |||
==[[Antithrombin III deficiency causes|Causes]]== | |||
==[[Antithrombin III deficiency differential diagnosis|Differentiating Antithrombin III deficiency from other Diseases]]== | |||
==[[Antithrombin III deficiency epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Antithrombin III deficiency risk factors|Risk Factors]]== | |||
==[[Antithrombin III deficiency screening|Screening]]== | |||
==[[Antithrombin III deficiency natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
==Diagnosis== | |||
[[Antithrombin III deficiency history and symptoms|History and Symptoms]] | [[Antithrombin III deficiency physical examination|Physical Examination]] | [[Antithrombin III deficiency laboratory findings|Laboratory Findings]] | [[Antithrombin III deficiency other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | |||
[[Antithrombin III deficiency medical therapy|Medical Therapy]] | [[Antithrombin III deficiency prevention|Prevention]] | [[Antithrombin III deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Antithrombin III deficiency future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Antithrombin III deficiency case study one|Case #1]] | |||
==Related Chapters== | ==Related Chapters== | ||
* [[Antithrombin]] | * [[Antithrombin]] | ||
Line 40: | Line 51: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[CME Category::Cardiology]] | |||
[[Category:Disease]] | [[Category:Disease]] |
Latest revision as of 22:48, 14 July 2020
Antithrombin III deficiency | |
ICD-9 | 289.81 |
---|---|
OMIM | 107300 |
DiseasesDB | 783 |
MeSH | D020152 |
For patient information click here
Antithrombin III deficiency Microchapters |
Differentiating Antithrombin III deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Antithrombin III deficiency On the Web |
American Roentgen Ray Society Images of Antithrombin III deficiency |
Directions to Hospitals Treating Antithrombin III deficiency |
Risk calculators and risk factors for Antithrombin III deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2], Sogand Goudarzi, MD [3]
Synonyms and keywords: Antithrombin 3 deficiency, Congenital AT-III Deficiancy,
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Antithrombin III deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies